Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 3035184, 13 pages
https://doi.org/10.1155/2017/3035184
Research Article

Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes

1Department of Endocrinology, Diabetes and Nutrition, Charité-University Medicine Berlin, Berlin, Germany
2Department of Endocrinology, Diabetes and Nutrition at the Center for Cardiovascular Research (CCR), Charité-University Medicine Berlin, Berlin, Germany
3Division of Physiology, Department of Zoology, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt
4Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany
5Section of Metabolic Vascular Medicine, Medical Clinic III, and Paul Langerhans Institute Dresden (PLID), Dresden University of Technology, Dresden, Germany
6Division of Diabetes & Nutritional Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK
7Department of Endocrinology, Diabetes and Nutrition at the Experimental and Clinical Research Centre (ECRC), Charité-University Medicine Berlin and Max-Delbrück Center Berlin-Buch, Berlin, Germany

Correspondence should be addressed to Ayman M. Arafat; ed.etirahc@tafara.namya

Received 13 September 2017; Accepted 23 October 2017; Published 20 December 2017

Academic Editor: Mohamed M. Abdel-Daim

Copyright © 2017 Biruhalem Assefa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Rinderknecht and R. E. Humbel, “The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin,” Journal of Biological Chemistry, vol. 253, no. 8, pp. 2769–2776, 1978. View at Google Scholar
  2. P. J. Smith, L. S. Wise, R. Berkowitz, C. Wan, and C. S. Rubin, “Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes,” Journal of Biological Chemistry, vol. 263, no. 19, pp. 9402–9408, 1988. View at Google Scholar
  3. S. D. O’Dell and I. N. M. Day, “Insulin-like growth factor II (IGF-II),” International Journal of Biochemistry & Cell Biology, vol. 30, no. 7, pp. 767–771, 1998. View at Google Scholar
  4. R. Monzavi and P. Cohen, “IGFs and IGFBPs: role in health and disease,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 16, no. 3, pp. 433–447, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Skottner, “Biosynthesis of growth hormone and insulin-like growth factor-I and the regulation of their secretion,” The Open Endocrinology Journal, vol. 6, no. 1, pp. 3–12, 2012. View at Publisher · View at Google Scholar
  6. S. T. Butler, A. L. Marr, S. H. Pelton, R. P. Radcliff, M. C. Lucy, and W. R. Butler, “Insulin restores GH responsiveness during lactation-induced negative energy balance in dairy cattle: effects on expression of IGF-I and GH receptor 1A,” Journal of Endocrinology, vol. 176, no. 2, pp. 205–217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. R. P. Rhoads, J. W. Kim, B. J. Leury et al., “Insulin increases the abundance of the growth hormone receptor in liver and adipose tissue of periparturient dairy cows,” The Journal of Nutrition, vol. 134, no. 5, pp. 1020–1027, 2004. View at Google Scholar
  8. D. R. Clemmons, “The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity,” The Journal of Clinical Investigation, vol. 113, no. 1, pp. 25–27, 2004. View at Publisher · View at Google Scholar
  9. L. A. Bach, S. J. Headey, and R. S. Norton, “IGF-binding proteins – the pieces are falling into place,” Trends in Endocrinology & Metabolism, vol. 16, no. 5, pp. 228–234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kutsukake, R. Ishihara, K. Momose et al., “Circulating IGF-binding protein 7 (IGFBP7) levels are elevated in patients with endometriosis or undergoing diabetic hemodialysis,” Reproductive Biology and Endocrinology, vol. 6, p. 54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. R. Clemmons, “Role of IGF binding proteins in regulating metabolism,” Trends in Endocrinology & Metabolism, vol. 27, no. 6, pp. 375–391, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther, “The insulin-like growth factor system and its pleiotropic functions in brain,” Endocrine Reviews, vol. 26, no. 7, pp. 916–943, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Mohan and D. J. Baylink, “IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms,” Journal of Endocrinology, vol. 175, no. 1, pp. 19–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. B. Wheatcroft and M. T. Kearney, “IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis,” Trends in Endocrinology & Metabolism, vol. 20, no. 4, pp. 153–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. M. Boney, B. M. Moats-Staats, A. D. Stiles, and A. J. D’Ercole, “Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis,” Endocrinology, vol. 135, no. 5, pp. 1863–1868, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Hoeflich, R. Reisinger, H. Lahm et al., “Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?” Cancer Research, vol. 61, no. 24, pp. 8601–8610, 2001. View at Google Scholar
  17. T. Fukushima and H. Kataoka, “Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma,” Anticancer Research, vol. 27, no. 6A, pp. 3685–3692, 2007. View at Google Scholar
  18. A. H. Heald, K. Kaushal, K. W. Siddals, A. S. Rudenski, S. G. Anderson, and J. M. Gibson, “Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome,” Experimental and Clinical Endocrinology & Diabetes, vol. 114, no. 07, pp. 371–376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Li and F. Picard, “Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity,” Hormone and Metabolic Research, vol. 42, no. 11, pp. 787–791, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Y. Nam, E. J. Lee, K. R. Kim et al., “Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone,” International Journal of Obesity, vol. 21, no. 5, pp. 355–359, 1997. View at Publisher · View at Google Scholar
  21. M. Claudio, F. Benjamim, B. Riccardo, C. Massimiliano, B. Francesco, and C. Luciano, “Adipocytes IGFBP-2 expression in prepubertal obese children,” Obesity, vol. 18, no. 10, pp. 2055–2057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. B. Wheatcroft, M. T. Kearney, A. M. Shah et al., “IGF-binding protein-2 protects against the development of obesity and insulin resistance,” Diabetes, vol. 56, no. 2, pp. 285–294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Hedbacker, K. Birsoy, R. W. Wysocki et al., “Antidiabetic effects of IGFBP2, a leptin-regulated gene,” Cell Metabolism, vol. 11, no. 1, pp. 11–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. W. Yau, V. C. Russo, I. J. Clarke, G. A. Werther, and M. A. Sabin, “IGFBP-2 enhances insulin signalling and glucose uptake in human skeletal myotubes,” Obesity Research & Clinical Practice, vol. 7, pp. e44–e45, 2013. View at Publisher · View at Google Scholar
  25. S. Woody, R. Stall, J. Ramos, and Y. M. Patel, “Regulation of myosin light chain kinase during insulin-stimulated glucose uptake in 3T3-L1 adipocytes,” PLoS One, vol. 8, no. 10, article e77248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Yamamoto, M. Ueda, T. Sato et al., “Measurement of glucose uptake in cultured cells,” Current Protocols in Pharmacology, vol. 12, pp. 12.14 11–12.14.22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. L. G. Laajoki, G. L. Francis, J. C. Wallace, J. A. Carver, and M. A. Keniry, “Solution structure and backbone dynamics of long-[Arg3]insulin-like growth factor-I,” Journal of Biological Chemistry, vol. 275, no. 14, pp. 10009–10015, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Ramlal, V. Sarabia, P. J. Bilan, and A. Klip, “Insulin-mediated translocation of glucose transporters from intracellular membranes to plasma membranes: sole mechanism of stimulation of glucose transport in L6 muscle cells,” Biochemical and Biophysical Research Communications, vol. 157, no. 3, pp. 1329–1335, 1988. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Kotani, W. Ogawa, M. Matsumoto et al., “Requirement of atypical protein kinase Cλ for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes,” Molecular and Cellular Biology, vol. 18, no. 12, pp. 6971–6982, 1998. View at Publisher · View at Google Scholar
  30. K. M. Rice and C. W. Garner, “IGF-I regulates IRS-1 expression in 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 255, no. 3, pp. 614–617, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. K. W. Siddals, M. Westwood, J. M. Gibson, and A. White, “IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte,” Journal of Endocrinology, vol. 174, no. 2, pp. 289–297, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Takahashi, Y. Takahashi, K. Takahashi et al., “Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes,” FEBS Letters, vol. 582, no. 5, pp. 573–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Berenguer, J. Zhang, M. C. Bruce et al., “Dimethyl sulfoxide enhances GLUT4 translocation through a reduction in GLUT4 endocytosis in insulin-stimulated 3T3-L1 adipocytes,” Biochimie, vol. 93, no. 4, pp. 697–709, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. K. C. Yuen and D. B. Dunger, “Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults,” Growth Hormone & IGF Research, vol. 16, Supplement A, pp. S55–S61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. K. C. Yuen and D. B. Dunger, “Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults,” Diabetes, Obesity and Metabolism, vol. 9, no. 1, pp. 11–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. M. Arafat, M. Möhlig, M. O. Weickert, C. Schöfl, J. Spranger, and A. F. Pfeiffer, “Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study,” Diabetologia, vol. 53, no. 7, pp. 1304–1313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. N. Rao, K. Mulligan, V. Tai et al., “Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 9, pp. 4361–4366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Schäffer, C. L. Brand, B. F. Hansen et al., “A novel high-affinity peptide antagonist to the insulin receptor,” Biochemical and Biophysical Research Communications, vol. 376, no. 2, pp. 380–383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Knudsen, B. F. Hansen, P. Jensen et al., “Agonism and antagonism at the insulin receptor,” PLoS One, vol. 7, no. 12, article e51972, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Siddle, “Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances,” Frontiers in Endocrinology, vol. 3, p. 34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Girnita, L. Girnita, F. del Prete, A. Bartolazzi, O. Larsson, and M. Axelson, “Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth,” Cancer Research, vol. 64, no. 1, pp. 236–242, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. B. C. Reed, S. H. Kaufmann, J. C. Mackall, A. K. Student, and M. D. Lane, “Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 11, pp. 4876–4880, 1977. View at Publisher · View at Google Scholar
  43. C. M. Boney, R. M. Smith, and P. A. Gruppuso, “Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation,” Endocrinology, vol. 139, no. 4, pp. 1638–1644, 1998. View at Publisher · View at Google Scholar
  44. S. Hong, H. Huo, J. Xu, and K. Liao, “Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae,” Cell Death and Differentiation, vol. 11, no. 7, pp. 714–723, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Boucher, Y. H. Tseng, and C. R. Kahn, “Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription,” Journal of Biological Chemistry, vol. 285, no. 22, pp. 17235–17245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. S. Chan, S. M. Twigg, S. M. Firth, and R. C. Baxter, “Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 12, pp. 6588–6595, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. M. A. Sabin, V. C. Russo, W. J. Azar, S. W. Yau, W. Kiess, and G. A. Werther, “IGFBP-2 at the interface of growth and metabolism--implications for childhood obesity,” Pediatric Endocrinology Reviews, vol. 8, no. 4, pp. 382–393, 2011. View at Google Scholar
  48. J. Frystyk, C. Skjaerbaek, E. Vestbo, S. Fisker, and H. Orskov, “Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 15, no. 5, pp. 314–322, 1999. View at Publisher · View at Google Scholar
  49. S. W. Yau, V. C. Russo, I. J. Clarke, F. R. Dunshea, G. A. Werther, and M. A. Sabin, “IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes,” International Journal of Obesity, vol. 39, no. 5, pp. 770–781, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. S. W. Yau, V. C. Russo, G. A. Werther, and M. A. Sabin, “IGFBP-2 enhances insulin signalling pathways in human skeletal muscle by cell surface binding – an IGF-independent process?” in Endocrine Society’s 96th Annual Meeting and Expo, Endocrine Society, Chicago, IL, USA, 2014, SAT-1072. View at Google Scholar
  51. V. C. Russo, B. S. Schütt, E. Andaloro et al., “Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion,” Endocrinology, vol. 146, no. 10, pp. 4445–4455, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. B. S. Schutt, M. Langkamp, U. Rauschnabel, M. B. Ranke, and M. W. Elmlinger, “Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells,” Journal of Molecular Endocrinology, vol. 32, no. 3, pp. 859–868, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Xi, C. J. Rosen, and D. R. Clemmons, “IGF-I and IGFBP-2 stimulate AMPK activation and autophagy, which are required for osteoblast differentiation,” Endocrinology, vol. 157, no. 1, pp. 268–281, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Siddle, “Signalling by insulin and IGF receptors: supporting acts and new players,” Journal of Molecular Endocrinology, vol. 47, no. 1, pp. R1–R10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Dupont and D. LeRoith, “Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction,” Hormone Research in Pædiatrics, vol. 55, Supplement 2, pp. 22–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. H. K. Karlsson, J. R. Zierath, S. Kane, A. Krook, G. E. Lienhard, and H. Wallberg-Henriksson, “Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects,” Diabetes, vol. 54, no. 6, pp. 1692–1697, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Zhang, Y. Liu, X. Li et al., “Effects of insulin and IGF-I on growth hormone- induced STAT5 activation in 3T3-F442A adipocytes,” Lipids in Health and Disease, vol. 12, p. 56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Suzuki, G. Kusakai, A. Kishimoto et al., “IGF-1 phosphorylates AMPK-α subunit in ATM-dependent and LKB1-independent manner,” Biochemical and Biophysical Research Communications, vol. 324, no. 3, pp. 986–992, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Shen, N. Honma, K. Kobayashi et al., “Cinnamon extract enhances glucose uptake in 3T3-L1 adipocytes and C2C12 myocytes by inducing LKB1-AMP-activated protein kinase signaling,” PLoS One, vol. 9, no. 2, article e87894, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. H. A. Koistinen, D. Galuska, A. V. Chibalin et al., “5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes,” Diabetes, vol. 52, no. 5, pp. 1066–1072, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Hayashi, M. F. Hirshman, E. J. Kurth, W. W. Winder, and L. J. Goodyear, “Evidence for 5 AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport,” Diabetes, vol. 47, no. 8, pp. 1369–1373, 1998. View at Publisher · View at Google Scholar
  62. X. Shen, G. Xi, L. A. Maile, C. Wai, C. J. Rosen, and D. R. Clemmons, “Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling,” Molecular and Cellular Biology, vol. 32, no. 20, pp. 4116–4130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. S. L. McGee, B. J. van Denderen, K. F. Howlett et al., “AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5,” Diabetes, vol. 57, no. 4, pp. 860–867, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Chen, J. Murphy, R. Toth, D. G. Campbell, N. A. Morrice, and C. Mackintosh, “Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators,” Biochemical Journal, vol. 409, no. 2, pp. 449–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. C. Pehmoller, J. T. Treebak, J. B. Birk et al., “Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle,” American Journal of Physiology - Endocrinology and Metabolism, vol. 297, no. 3, pp. E665–E675, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. E. B. Taylor, D. An, H. F. Kramer et al., “Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle,” Journal of Biological Chemistry, vol. 283, no. 15, pp. 9787–9796, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Sano, S. Kane, E. Sano et al., “Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation,” Journal of Biological Chemistry, vol. 278, no. 17, pp. 14599–14602, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Ishiki and A. Klip, “Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners,” Endocrinology, vol. 146, no. 12, pp. 5071–5078, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. G. Bandyopadhyay, M. L. Standaert, M. P. Sajan et al., “Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-ζ,” Molecular Endocrinology, vol. 13, no. 10, pp. 1766–1772, 1999. View at Publisher · View at Google Scholar
  70. M. Tsuru, H. Katagiri, T. Asano et al., “Role of PKC isoforms in glucose transport in 3T3-L1 adipocytes: insignificance of atypical PKC,” American Journal of Physiology - Endocrinology and Metabolism, vol. 283, no. 2, pp. E338–E345, 2002. View at Publisher · View at Google Scholar